Abstract 2898: Prognostic value of postoperative alpha-fetoprotein level on recurrence after curative resection for hepatocellular carcinoma
Daisuke Nobuoka(Fukuyama City Hospital), Tetsuya Nakatsura(Unknown), Shinichiro Takahashi(Shizuoka Cancer Center), Yuichiro Kato(National Cancer Center Hospital East), Taira Kinoshitá(National Cancer Center Hospital East), Masaru Konishi(Shizuoka Cancer Center), Naoto Gotohda(Shizuoka Cancer Center)
Cited by 0
Related Papers
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas
|Journal of Hepato-Biliary-Pancreatic Sciences|2011|289
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition
|Journal of Hepato-Biliary-Pancreatic Sciences|2020|235